Author:
Moelans Cathy B.,Vlug Eva J.,Ercan Cigdem,Bult Peter,Buerger Horst,Cserni Gabor,van Diest Paul J.,Derksen Patrick W. B.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Reference48 articles.
1. G. Arpino, V.J. Bardou, G.M. Clark, R.M. Elledge, Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 6, R149 (2004)
2. E. Gudlaugsson, I. Skaland, E.A.M. Janssen, P.J. Van Diest, F.J. Voorhorst, K. Kjellevold, A.z. Hausen, J.P.A. Baak, Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer. Breast Cancer Res. Treat. 121, 35–40 (2010)
3. E. Vlug, C. Ercan, E. Wall, P. J. Diest, P. W. B. Derksen, Lobular Breast Cancer: Pathology, Biology, and Options for Clinical Intervention Arch. Immunol. Ther. Exp. 1–15 (2013)
4. G. Berx, A.M. Cleton-Jansen, K. Strumane, W.J. de Leeuw, F. Nollet, F. Van Roy, C. Cornelisse, E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13, 1919–1925 (1996)
5. P.W.B. Derksen, X. Liu, F. Saridin, H. Van Der Gulden, J. Zevenhoven, B. Evers, J.R. van Beijnum, A.W. Griffioen, J. Vink, P. Krimpenfort, J.L. Peterse, R.D. Cardiff, A. Berns, J. Jonkers, Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 10, 437–449 (2006)
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献